CONNECT WITH US
Tech

Tech

Measles is back. This tool calculates the exact cost to our economy

Fast Company logo

Published on

Add as a preferred source on Google
Measles is back. This tool calculates the exact cost to our economy

Measles is making a comeback, and the outbreak isn’t just costing Americans their health. The surge is also costing the U.S. economy millions.

In 2025, the United States experienced the largest number of measles cases since its elimination in 2000. Falling vaccination rates fueled the surge, which has roared back with 5,182 cases reported in 2026 alone as of early November, according to the Centers for Disease Control and Prevention (CDC).

For some context, a total of 2,289 cases were confirmed in 2025—less than half of what we are seeing so far this year. Hardest hit is the state of Pennsylvania, where six people have died. In addition, one person has died in New York and another in Wisconsin. The CDC’s most recent map shows measles cases in almost all U.S. states.

The costs could continue to rise as the epidemic gets worse, according to a new tool from Johns Hopkins University, which calculated the cost for the outbreak in 2025 at more than $37 million. Overall, the tool estimates the measles outbreak has cost nearly $83 million, including $56 million for the public health response, $25 million in lost productivity, and more than $1.8 million in medical expenses.

That analysis looked at measles outbreaks across 18 states, and found it costs about $250,000 initially to respond to each outbreak, regardless of its size, plus roughly $16,300 per additional case. 

“Whether it’s one case or 20 cases, those initial mobilization costs are incurred,” measles study coauthor Bryan Patenaude, a health economist at the International Vaccine Access Center (IVAC) at JHU in Baltimore, said in a release .


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.